logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12653874 B1

PDFFull Text
Date of Patent:
Jun. 16, 2026

Filed:

Aug. 03, 2022

Nant cancer vaccine

Applicants:

Nantcell, Inc., Culver City, CA (US);

Nant Holdings Ip, Llc, Culver City, CA (US);

Inventors:

Patrick Soon-Shiong, Culver City, CA (US);

Kayvan Niazi, Culver City, CA (US);

Shahrooz Rabizadeh, Agoura Hills, CA (US);

Hans G. Klingemann, Culver City, CA (US);

Laurent H. Boissel, Culver City, CA (US);

Barry J. Simon, Culver City, CA (US);

Assignees:

ImmunityBio, Inc., San Diego, CA (US);

NantCell, Inc., Culver City, CA (US);

Attorneys:

Umberg Zipser LLP

Martin Fessenmaier

Priti Phukan

Primary Examiner:

Laura B Goddard

Int. Cl.
CPC ...
A61K 40/15 (2025.01); A61K 9/14 (2006.01); A61K 31/337 (2006.01); A61K 38/20 (2006.01); A61K 39/00 (2006.01); A61K 40/31 (2025.01); A61K 40/42 (2025.01); A61P 35/00 (2006.01); C07K 14/54 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001152 (2018.08); A61K 38/2013 (2013.01); A61K 38/2046 (2013.01); A61K 38/2086 (2013.01); A61K 39/0011 (2013.01); A61K 39/001106 (2018.08); A61K 39/001164 (2018.08); A61K 39/00117 (2018.08); A61K 39/001182 (2018.08); A61K 40/15 (2025.01); A61K 40/31 (2025.01); A61K 40/4205 (2025.01); A61K 40/4242 (2025.01); A61K 40/4253 (2025.01); A61K 40/4257 (2025.01); A61K 40/4266 (2025.01); C07K 16/2827 (2013.01); A61K 2039/507 (2013.01); A61K 2039/523 (2013.01); A61K 2239/31 (2023.05); A61K 2239/38 (2023.05); A61K 2239/48 (2023.05); A61K 2239/57 (2023.05); C07K 2317/76 (2013.01);
Abstract

Cancer is treated using coordinated treatment regimens that uses various compounds and compositions that drive a tumor from the escape phase of cancer immunoediting to the elimination and equilibrium phase of cancer immunoediting.

Find Patent Forward Citations

Quick Actions:

Soon-Shiong, Patrick. (2026). Nant cancer vaccine (U.S. Patent No. 12653874). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12653874

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…